Morphic to Present at November Investor Conferences
2023年11月10日 - 10:00PM
Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company
developing a new generation of oral integrin therapies for the
treatment of serious chronic diseases, today announced that its
management team will participate in the upcoming Jefferies London
Healthcare Conference and Evercore ISI HealthCONx Conference.
Jefferies London Healthcare Conference
Fireside Chat Date: Tuesday, November 14, 2023Time: 5:00
PM GMT/12:00 PM ETA live webcast of the presentation will be
available on the Investor section of the Morphic website. An
archived replay will be available on the company’s website
following the conference.
Evercore ISI HealthCONx Conference
Presentation Date: Thursday, November 30, 2023Time: 9:10
AM ETA live webcast of the presentation will be available on the
Investor section of the Morphic website. An archived replay will be
available on the company’s website following the conference.
About Morphic
TherapeuticMorphic Therapeutic is a biopharmaceutical
company developing a portfolio of oral integrin therapies for the
treatment of serious chronic diseases, including autoimmune,
cardiovascular, and metabolic diseases, fibrosis, and cancer.
Morphic is also advancing its pipeline and discovery activities in
collaboration with Schrödinger using its proprietary MInT
technology platform which leverages the Company’s unique
understanding of integrin structure and biology. For more
information, visit www.morphictx.com.
ContactsMorphic
TherapeuticChris Erdmanchris.erdman@morphictx.com617.686.1718
Morphic (NASDAQ:MORF)
過去 株価チャート
から 8 2024 まで 9 2024
Morphic (NASDAQ:MORF)
過去 株価チャート
から 9 2023 まで 9 2024